Drug Shortage Report for LUPRON DEPOT

Last updated on 2020-06-27 History
Report ID 118920
Drug Identification Number 02239834
Brand name LUPRON DEPOT
Common or Proper name Lupron depot 11.25mg
Company Name ABBVIE CORPORATION
Market Status MARKETED
Active Ingredient(s) LEUPROLIDE ACETATE
Strength(s) 11.25MG
Dosage form(s) POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 1 syringe (11.25mg)
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-06-26
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-06-27
Company comments We are currently monitoring our inventory of Lupron 11,25mg (3 month) due to a manufacturing delay. AbbVie is acting quickly to minimize any potential impact from this situation, by managing existing inventory. During that period, orders will be processed to supply minimal quantity required to meet patient needs. Please contact our Customer Services Department for Lupron 3,75mg (1 month) or Orilissa 200mg BID as possible alternatives at 1-888-704-8270.
Health Canada comments
Contact Address 8401 TRANS-CANADA HIGHWAY
SAINT-LAURENT, QUEBEC
CANADA H4S 1Z1
Company contact information Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-06-27 English Compare
v4 2020-06-26 French Compare
v3 2020-06-26 English Compare
v2 2020-06-26 English Compare
v1 2020-06-25 English Compare